247
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999–2008 and treated with curative intent in the AIDS Malignancy Consortium

, , , , , , , , , , , , & show all
Pages 2383-2389 | Received 13 Jan 2012, Accepted 21 May 2012, Published online: 09 Jul 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Chia-Ching J. Wang & Lawrence D. Kaplan. (2016) Clinical management of HIV-associated hematologic malignancies. Expert Review of Hematology 9:4, pages 361-376.
Read now

Articles from other publishers (15)

Juan C. Ramos, Joseph A. SparanoAmy ChadburnErin G. Reid, Richard F. Ambinder, Eric R. Siegel, Page C. MoorePaul G. Rubinstein, Christine M. DurandEthel CesarmanDavid AboulafiaRobert Baiocchi, Lee RatnerLawrence KaplanAdam A. Capoferri, Jeannette Y. LeeRonald MitsuyasuAriela Noy. (2020) Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial). Blood 136:11, pages 1284-1297.
Crossref
Shotaro Hagiwara, Hirokazu Nagai, Tomoko Uehira, Akiko M. Saito & Seiji Okada. (2019) Autologous peripheral blood stem cell transplantation for relapsed/refractory HIV-associated lymphoma: a phase II clinical study. International Journal of Hematology 111:3, pages 434-439.
Crossref
Jesus Anampa, Stefan K. Barta, Missak Haigentz & Joseph A. Sparano. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 894 903.e4 .
Alanna Maguire, Xianfeng Chen, Lee Wisner, Smriti Malasi, Colleen Ramsower, Samantha Kendrick, Michael T. Barrett, Betty Glinsmann‐Gibson, Michael McGrath & Lisa M. Rimsza. (2019) Enhanced DNA repair and genomic stability identify a novel HIV‐related diffuse large B‐cell lymphoma signature. International Journal of Cancer.
Crossref
Erin G. Reid, David LooneyFrank Maldarelli, Ariela Noy, David HenryDavid Aboulafia, Juan Carlos Ramos, Joseph Sparano, Richard F. AmbinderJeannette LeeEthel Cesarman, Sara Yahyaei, Ronald Mitsuyasu & William Wachsman. (2018) Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas. Blood Advances 2:24, pages 3618-3626.
Crossref
Haiyan Min, Jianwei Yang, Sanbin Wang, Pengfei Tao, Yuqin Song, Xiaopei Wang, Huiqin Li, Xinping Yang, Xingqi Dong, Fu-Sheng Wang, Ming Shi, Xicheng Wang & Ruonan Xu. (2018) Remission of HIV-related naïve and high-risk Burkitt’s lymphoma treated by autologous stem cell transplantation plus cART. Stem Cell Research & Therapy 9:1.
Crossref
Pilar Miralles, José Tomás Navarro, Juan Berenguer, José Gómez Codina, Mi Kwon, David Serrano, José Luis Díez-Martín, Salvador Villà, Rafael Rubio, Javier Menárguez & José-María Ribera Santasusana. (2018) Recomendaciones de GESIDA/PETHEMA sobre el diagnóstico y tratamiento de los linfomas en pacientes infectados por el virus de la inmunodeficiencia humana. Medicina Clínica 151:1, pages 39.e1-39.e17.
Crossref
Pilar Miralles, José Tomás Navarro, Juan Berenguer, José Gómez Codina, Mi Kwon, David Serrano, José Luis Díez-Martín, Salvador Villà, Rafael Rubio, Javier Menárguez & José-María Ribera Santasusana. (2018) GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus. Medicina Clínica (English Edition) 151:1, pages 39.e1-39.e17.
Crossref
Juan C. Ramos, Joseph A. Sparano, Michelle A. Rudek, Page C. Moore, Ethel Cesarman, Erin G. Reid, David Henry, Lee Ratner, David Aboulafia, Jeanette Y. Lee, Richard F. Ambinder, Ronald Mitsuyasu & Ariela Noy. (2018) Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075). Clinical Lymphoma Myeloma and Leukemia 18:3, pages 180-190.e2.
Crossref
R Ramaswami, A Dalla Pria, K Parker, S McCann, E J Kanfer, M Nelson & M Bower. (2016) Outcomes of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory HIV-associated lymphoma. Bone Marrow Transplantation 51:12, pages 1609-1611.
Crossref
Yusuke Koizumi, Tomoko Uehira, Yasunori Ota, Yoshihiko Ogawa, Keishiro Yajima, Junko Tanuma, Mihoko Yotsumoto, Shotaro Hagiwara, Satoshi Ikegaya, Dai Watanabe, Hitoshi Minamiguchi, Keiko Hodohara, Kenta Murotani, Hiroshige Mikamo, Hideho Wada, Atsushi Ajisawa, Takuma Shirasaka, Hirokazu Nagai, Yoshinori Kodama, Tsunekazu Hishima, Makoto Mochizuki, Harutaka Katano & Seiji Okada. (2016) Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases. International Journal of Hematology 104:6, pages 669-681.
Crossref
Stefan K. Barta, Kieron Dunleavy & Nicolas Mounier. 2016. HIV-associated Hematological Malignancies. HIV-associated Hematological Malignancies 39 65 .
Thomas S. Uldrick & Richard F. Little. (2015) How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus. Blood 125:8, pages 1226-1235.
Crossref
Antonino Carbone, Emanuela Vaccher, Annunziata Gloghini, Liron Pantanowitz, Akin Abayomi, Paolo de Paoli & Silvia Franceschi. (2014) Diagnosis and management of lymphomas and other cancers in HIV-infected patients. Nature Reviews Clinical Oncology 11:4, pages 223-238.
Crossref
Seiji Okada, Hiroki Goto & Mihoko Yotsumoto. (2014) Current status of treatment for primary effusion lymphoma. Intractable & Rare Diseases Research 3:3, pages 65-74.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.